- Home
- STIM vs FLC Comparison
STIM vs FLC Comparison
Compare STIM & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- FLC
- Stock Information
- Founded
- STIM 2003
- FLC 2003
- Country
- STIM United States
- FLC United States
- Employees
- STIM N/A
- FLC N/A
- Industry
- STIM Medical/Dental Instruments
- FLC Trusts Except Educational Religious and Charitable
- Sector
- STIM Health Care
- FLC Finance
- Exchange
- STIM Nasdaq
- FLC Nasdaq
- Market Cap
- STIM 224.8M
- FLC 186.8M
- IPO Year
- STIM 2018
- FLC N/A
- Fundamental
- Price
- STIM $1.97
- FLC $17.61
- Analyst Decision
- STIM Strong Buy
- FLC
- Analyst Count
- STIM 2
- FLC 0
- Target Price
- STIM $7.00
- FLC N/A
- AVG Volume (30 Days)
- STIM 1.6M
- FLC 37.8K
- Earning Date
- STIM 11-04-2025
- FLC 01-01-0001
- Dividend Yield
- STIM N/A
- FLC 6.64%
- EPS Growth
- STIM N/A
- FLC N/A
- EPS
- STIM N/A
- FLC N/A
- Revenue
- STIM $129,873,000.00
- FLC N/A
- Revenue This Year
- STIM $105.70
- FLC N/A
- Revenue Next Year
- STIM $11.77
- FLC N/A
- P/E Ratio
- STIM N/A
- FLC N/A
- Revenue Growth
- STIM 78.61
- FLC N/A
- 52 Week Low
- STIM $0.60
- FLC $12.62
- 52 Week High
- STIM $5.92
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- STIM 28.30
- FLC 43.35
- Support Level
- STIM $2.01
- FLC $17.52
- Resistance Level
- STIM $3.09
- FLC $17.72
- Average True Range (ATR)
- STIM 0.25
- FLC 0.13
- MACD
- STIM -0.08
- FLC -0.01
- Stochastic Oscillator
- STIM 6.88
- FLC 26.67
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.